Label-free quantitative proteomic analysis of serum exosomes from patients of renal anemia: The Good and the Bad of Roxadustat

BACKGROUND: Roxadustat is a new oral anti-renal anemia medication that works by stabilizing hypoxia-inducible factor (HIF) which can activate the expression of more than 100 genes in addition to genes related to anemia. However, the more potential molecular targets of roxadustat are not completely c...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Xiaoe, Guo, Baochun, Wang, Zhen, Ma, Hualin, Zhang, Xinzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187900/
https://www.ncbi.nlm.nih.gov/pubmed/35690731
http://dx.doi.org/10.1186/s12014-022-09358-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187900/
https://www.ncbi.nlm.nih.gov/pubmed/35690731
http://dx.doi.org/10.1186/s12014-022-09358-w

Ejemplares similares